当前位置: 首页 > 期刊 > 《中外医学研究》 > 201336
编号:13708050
小剂量美罗华联合新鲜冰冻血浆治疗难治性免疫性血小板减少症疗效观察(3)
http://www.100md.com 2013年12月25日 《中外医学研究》 201336
     [9]Stanglmaier M,Reis S,Hallek M.Rituximab and alemtuzumab induce a nonclassic,caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells[J].Annals of hematology,2004,83(10):634-645.

    [10]Kelly K,Gleeson M,Murphy P T.Slow responses to standard dose rituximab in immune thrombocytopenic purpura[J].Haematologica,2009,94(3):443-444.

    [11]Stasi R,Pagano A,Stipa E,et al.Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura[J].Blood,2001,98(4):952-957.

    [12]Arnold D M,Dentali F,Crowther M A,et al.Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura[J].Annals of Internal Medicine,2007,146(1):25-33.

    [13]Zaja F,Vianelli N,Volpetti S,et al.Low‐dose rituximab in adult patients with primary immune thrombocytopenia[J].European Journal of Haematology,2010,85(4):329-334.

    [14]孙梅,顾健,何斌,等.小剂量美罗华联合冰冻血浆治疗免疫性血小板减少症[J].血栓与止血学,2010,16(1):18-20.

    (收稿日期:2013-08-25) (编辑:王韵), http://www.100md.com(丁艳等)
上一页1 2 3